Criteria
|
AUC (CI 95%)
|
Cut point = 1
|
---|
| |
Sensitivity (CI 95%)
|
Specificity (CI 95%)
|
PPV1(CI 95%)
|
NPV2(CI 95%)
|
---|
ASCO criteria3
|
0.85 (0.81–0.89)
|
97.0 (91–100)
|
52.0 (50–55)
|
7.0 (6–9)
|
100.0 (99–100)
|
High risk HBOC syndrome4
|
0.86 (0.82–0.90)
|
97.0 (92–100)
|
53.0 (50–55)
|
8.0 (7–10)
|
100.0 (99–100)
|
HBCC criteria3
|
0.86 (0.84–0.88)
|
100.0 (89–100)
|
51.0 (49–54)
|
3.0 (2–4)
|
100.0
|
LFL syndrome3
|
0.72 (0.68–0.76)
|
83.0 (77–88)
|
54.0 (52–56)
|
16.0 (14–18)
|
97.0 (96–98)
|
HBC syndrome (overall)5
|
0.83 (0.81–0.85)
|
88.0 (83–91)
|
56.0 (54–59)
|
24.0 (21–27)
|
97.0 (95–98)
|
-
1 PPV = positive predictive value.
-
2 NPV = negative predictive value.
-
3 Criteria as described in materials and methods.
-
4 ASCO criteria and/or estimated prior probability of a BRCA mutation ≥30%.
-
5 Includes Hereditary Breast and Ovarian Cancer (HBOC), Hereditary Breast and Colorectal Cancer (HBCC) and Li-Fraumeni-like syndrome (LFL) criteria.